Two South Korean conglomerates just announced they tested tokenizing live trade receivables on Injective. The press release calls it a step toward 'reshaping global finance.' I call it a carefully staged proof-of-concept that reveals more about our industry's thirst for narratives than about actual technical progress. Code does not lie, but the auditors often do. Here, we have no code, no audit, and no clarity on the legal foundation.
Context: The RWA Hype meets enterprise pilots
LG CNS, the IT arm of LG Group, partnered with POSCO International, the trading and energy subsidiary of POSCO, to tokenize trade receivables—essentially converting unpaid invoices into blockchain-based tokens. The test ran on Injective, a layer-1 blockchain focused on derivatives and cross-chain finance. This is a classic real-world asset (RWA) tokenization experiment, a category that has become the darling of crypto VCs in 2025-2026. But let’s not confuse a pilot with production. The companies explicitly called it a 'concept verification test,' not a live deployment. In my years auditing DeFi protocols, I’ve learned that press releases are not technical documents.
Core: The structural fragility of off-chain dependencies
Let’s dissect what actually happens in such a tokenization. A trade receivable is a legal claim on future payment. To tokenize it, you need three things: a smart contract representing the claim, a custodian or legal entity holding the off-chain title, and an oracle or mechanism to prove the receivable is valid and collectable. The article mentions none of these details. Based on my experience auditing early RWA projects during the NFT boom—where I found 40% of 'decentralized' NFT collections relying on centralized JSON servers—I can spot the same pattern here. The real risk is not in the EVM bytecode; it’s in the legal wrapper. Who holds the legal title to the receivable? Is it LG CNS, POSCO, or a separate special purpose vehicle? If the token holder sues, which jurisdiction applies? These are not theoretical questions.
Furthermore, the pilot likely uses a permissioned investor pool with whitelisted addresses. That’s fine for a test, but it means the tokens are not liquid on any secondary market. The 'value' is purely bilateral. The team’s silence on the token standard—ERC-721 or ERC-1155?—suggests they haven’t yet considered composability with DeFi. Security is a process, not a badge you wear. And this project hasn’t even passed the first gate of public audit.
Contrarian: What the bulls get right—and wrong
The optimistic interpretation: two major traditional companies are experimenting with public blockchains. That is, in itself, a signal. Injective gains a use case beyond speculative trading. If the pilot proves 'successful,' it could open the door for other Korean chaebols like Samsung or Hyundai to follow. The RWA narrative gains another data point.
But here’s the blind spot: the same bullish argument was used for every enterprise blockchain project of the last decade—Hyperledger, Quorum, Corda. None of them led to widespread adoption because the bottlenecks are not technical but legal and organizational. This pilot does not solve the problem of asset custody or regulatory classification. In fact, under the Howey test, a trade receivable token is almost certainly a security. That means every transfer would require KYC/AML checks and potential registration. The article’s grand vision of 'reshaping ecosystems' conveniently ignores that the product, if scaled, would first need to navigate securities laws across Korea, the US (since POSCO operates globally), and the EU.
Takeaway: Treat press releases as experimental data, not investment theses
This pilot is a footnote, not a chapter. It validates that a specific smart contract can emit a token representing a receivable. It does not validate that the legal system will honor that token, that liquidity providers will trust it, or that regulators will allow it. My advice: set a calendar reminder for 12 months from now. Check if the pilot expanded, if the tokens were traded outside the consortium, or if a regulatory filing was made. Until then, this is a house of cards on a ledger of trust.